Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn | -99.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.70% |
| Mar 31, 2026 | -0.85% |
| Dec 31, 2025 | -253.48% |
| Sep 30, 2025 | 3.85% |
| Jun 30, 2025 | 38.15% |
| Mar 31, 2025 | 24.75% |
| Dec 31, 2024 | -419.78% |
| Sep 30, 2024 | -29.67% |
| Jun 30, 2024 | -7.11% |
| Mar 31, 2024 | -19.61% |
| Dec 31, 2023 | -75.28% |
| Sep 30, 2023 | 340.14% |
| Jun 30, 2023 | -20.22% |
| Mar 31, 2023 | 915.98% |
| Dec 31, 2022 | 66.68% |
| Sep 30, 2022 | 8.21% |
| Jun 30, 2022 | -34.61% |
| Mar 31, 2022 | -105.24% |
| Dec 31, 2021 | -42.57% |
| Sep 30, 2021 | 993.11% |